Deep Learning for Chronic Disease Diagnosis, Prediction, Monitoring, and Treatment

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Machine Learning and Artificial Intelligence in Diagnostics".

Deadline for manuscript submissions: closed (1 July 2021) | Viewed by 28251

Special Issue Editors


E-Mail Website
Guest Editor
Centro Singular de Investigación en Tecnoloxías Intelixentes (CiTIUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
Interests: artificial Intelligence; semantic web; medical informatics

E-Mail Website
Guest Editor
Cyber Security Department, Visa Inc, USA; Department of Computer Science, University of Alabama at Birmingham (UAB), Birmingham, AL 35294, USA
Interests: cybersecurity; Internet of Things; cloud computing; embedded systems

E-Mail Website
Guest Editor
Department of Computer Science, Northern Kentucky University, Highland Heights, KY 41099, USA
Interests: cloud computing; Internet of Things; cyber security

Special Issue Information

Dear colleagues,

Chronic diseases such as dementia and diabetes, among others, immensely impact the lives of patients, their families, and societies. The wide availability of digital technologies in Healthcare 4.0 facilitates the delivery of more effective and efficient healthcare services. These technologies have the potential to reduce healthcare costs, improve user experience, and increase the quality of care. Using machine learning (ML), deep learning (DL) and other artificial intelligence (AI) technologies to automate chronic-disease management is expected to help healthcare providers (e.g., health practitioners, hospitals, and clinics) in daily practice to serve more patients in a more efficient manner. However, making personalized decisions in chronic-disease management requires the integration of huge and heterogeneous data from the hospital’s electronic health records, including neuroimaging (e.g., MRI and CT), lab tests, time series, sound waves, ECG, text, etc. DL algorithms such as CNN (convolutional neural network), RNN (recurrent neural network), RBM (restricted Boltzmann machine), autoencoder, and FFNN (feed forward neural network) have rapidly evolved and recently gained an ever-increasing role in the medical domain. They achieve superior performance compared to regular machine-learning algorithms such as SVM (support vector machine), random forest, KNN (k nearest neighbors), and decision trees. Deep-learning algorithms can automatically extract complex and deep representations from large and unstructured data such as images, sound, and text. In addition, building hybrid models and ensembles of deep-learning models even further improves modern deep-learning techniques. However, the optimization of these models is a challenging task, and implementing customized data preprocessing pipelines is another critical step for building high-performing models. The implementation of such AI-oriented diagnostic frameworks therefore requires more sophisticated approaches, which would be sustainable and inclusive in nature. This Special Issue aims to provide a platform to researchers for sharing recent novel advances in the application of DL and AI models in chronic-disease diagnosis, prediction, monitoring, and treatment.

Both theoretical and practical papers are solicited on the following related aspects: algorithms, system design, performance analysis, experimental studies, and review studies. Potential topics include, but are not limited to, the themes listed below:

  • The key techniques and applications of AI-based disease diagnosis;
  • The integration of DL and ontology reasoning;
  • DL-based uncertainty management;
  • AutoML’s role in optimizing DL models;
  • Alzheimer’s disease diagnosis, progression detection, and monitoring;
  • Multitask modeling using DL;
  • Building hybrid DL models;
  • The interpretability of DL models’ decisions;
  • Image visualization for explaining DL decisions;
  • Big data fusion and multimodal data;
  • Ensemble deep-learning models for chronic-disease management;
  • Biomarker identification using multiomics analysis;
  • Secure healthcare services and applications.

Dr. Shaker El-Sappagh
Dr. Mahmud Hossain
Dr. Shahid Al Noor
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Artificial intelligence
  • Disease diagnosis
  • Machine learning
  • Deep learning
  • Medical informatics
  • Bioinformatics
  • Industry 4.0
  • Data analysis
  • Healthcare security.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (5 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

22 pages, 2520 KiB  
Article
Vocal Feature Extraction-Based Artificial Intelligent Model for Parkinson’s Disease Detection
by Muntasir Hoq, Mohammed Nazim Uddin and Seung-Bo Park
Diagnostics 2021, 11(6), 1076; https://doi.org/10.3390/diagnostics11061076 - 11 Jun 2021
Cited by 57 | Viewed by 6375
Abstract
As a neurodegenerative disorder, Parkinson’s disease (PD) affects the nerve cells of the human brain. Early detection and treatment can help to relieve the symptoms of PD. Recent PD studies have extracted the features from vocal disorders as a harbinger for PD detection, [...] Read more.
As a neurodegenerative disorder, Parkinson’s disease (PD) affects the nerve cells of the human brain. Early detection and treatment can help to relieve the symptoms of PD. Recent PD studies have extracted the features from vocal disorders as a harbinger for PD detection, as patients face vocal changes and impairments at the early stages of PD. In this study, two hybrid models based on a Support Vector Machine (SVM) integrating with a Principal Component Analysis (PCA) and a Sparse Autoencoder (SAE) are proposed to detect PD patients based on their vocal features. The first model extracted and reduced the principal components of vocal features based on the explained variance of each feature using PCA. For the first time, the second model used a novel Deep Neural Network (DNN) of an SAE, consisting of multiple hidden layers with L1 regularization to compress the vocal features into lower-dimensional latent space. In both models, reduced features were fed into the SVM as inputs, which performed classification by learning hyperplanes, along with projecting the data into a higher dimension. An F1-score, a Mathews Correlation Coefficient (MCC), and a Precision-Recall curve were used, along with accuracy to evaluate the proposed models due to highly imbalanced data. With its highest accuracy of 0.935, F1-score of 0.951, and MCC value of 0.788, the probing results show that the proposed model of the SAE-SVM surpassed not only the former model of the PCA-SVM and other standard models including Multilayer Perceptron (MLP), Extreme Gradient Boosting (XGBoost), K-Nearest Neighbor (KNN), and Random Forest (RF), but also surpassed two recent studies using the same dataset. Oversampling and balancing the dataset with SMOTE boosted the performance of the models. Full article
Show Figures

Figure 1

12 pages, 2204 KiB  
Article
Machine-Learning-Based Rehabilitation Prognosis Prediction in Patients with Ischemic Stroke Using Brainstem Auditory Evoked Potential
by Jangjay Sohn, Il-Young Jung, Yunseo Ku and Yeongwook Kim
Diagnostics 2021, 11(4), 673; https://doi.org/10.3390/diagnostics11040673 - 8 Apr 2021
Cited by 13 | Viewed by 2878
Abstract
To evaluate the feasibility of brainstem auditory evoked potential (BAEP) for rehabilitation prognosis prediction in patients with ischemic stroke, 181 patients were tested using the Korean version of the modified Barthel index (K-MBI) at admission (basal K-MBI) and discharge (follow-up K-MBI). The BAEP [...] Read more.
To evaluate the feasibility of brainstem auditory evoked potential (BAEP) for rehabilitation prognosis prediction in patients with ischemic stroke, 181 patients were tested using the Korean version of the modified Barthel index (K-MBI) at admission (basal K-MBI) and discharge (follow-up K-MBI). The BAEP measurements were performed within two weeks of admission on average. The criterion between favorable and unfavorable outcomes was defined as a K-MBI score of 75 at discharge, which was the boundary between moderate and mild dependence in daily living activities. The changes in the K-MBI scores (discharge-admission) were analyzed by nonlinear regression models, including the artificial neural network (ANN) and support vector machine (SVM), with the basal K-MBI score, age, and interpeak latencies (IPLs) of the BAEP (waves I, I–III, and III–V). When including the BAEP features, the correlations of the ANN and SVM regression models increased to 0.70 and 0.64, respectively. In the outcome prediction, the ANN model with the basal K-MBI score, age, and BAEP IPLs exhibited a sensitivity of 92% and specificity of 90%. Our results suggest that the BAEP IPLs used with the basal K-MBI score and age can play an adjunctive role in the prediction of patient rehabilitation prognoses. Full article
Show Figures

Figure 1

13 pages, 1284 KiB  
Article
Prediction of Hypertension Based on Facial Complexion
by Lin Ang, Bum Ju Lee, Honggie Kim and Mi Hong Yim
Diagnostics 2021, 11(3), 540; https://doi.org/10.3390/diagnostics11030540 - 17 Mar 2021
Cited by 3 | Viewed by 3236
Abstract
This study aims to investigate the association between hypertension and facial complexion and determine whether facial complexion is a predictor for hypertension. Using the Commission internationale de l’éclairage L*a*b* (CIELAB) color space, the facial complexion variables of 1099 subjects were extracted in three [...] Read more.
This study aims to investigate the association between hypertension and facial complexion and determine whether facial complexion is a predictor for hypertension. Using the Commission internationale de l’éclairage L*a*b* (CIELAB) color space, the facial complexion variables of 1099 subjects were extracted in three regions (forehead, cheek, and nose) and the total face. Logistic regression was performed to analyze the association between hypertension and individual color variables. Four variable selection methods were also used to assess the association between hypertension and combined complexion variables and to compare the predictive powers of the models. The a* (green-red) complexion variables were identified as strong predictors in all facial regions in the crude analysis for both genders. However, this association in men disappeared, and L* (lightness) variables in women became the strongest predictors after adjusting for age and body mass index. Among the four prediction models based on combined complexion variables, the Bayesian approach obtained the best predictive in men. In women, models using three different methods but not the stepwise Akaike information criterion (AIC) obtained similar AUC values between 0.82 and 0.83. The use of combined facial complexion variables slightly improved the predictive power of hypertension in all four of the models compared with the use of individual variables. Full article
Show Figures

Figure 1

Review

Jump to: Research

24 pages, 7537 KiB  
Review
Bias Investigation in Artificial Intelligence Systems for Early Detection of Parkinson’s Disease: A Narrative Review
by Sudip Paul, Maheshrao Maindarkar, Sanjay Saxena, Luca Saba, Monika Turk, Manudeep Kalra, Padukode R. Krishnan and Jasjit S. Suri
Diagnostics 2022, 12(1), 166; https://doi.org/10.3390/diagnostics12010166 - 11 Jan 2022
Cited by 55 | Viewed by 6597
Abstract
Background and Motivation: Diagnosis of Parkinson’s disease (PD) is often based on medical attention and clinical signs. It is subjective and does not have a good prognosis. Artificial Intelligence (AI) has played a promising role in the diagnosis of PD. However, it introduces [...] Read more.
Background and Motivation: Diagnosis of Parkinson’s disease (PD) is often based on medical attention and clinical signs. It is subjective and does not have a good prognosis. Artificial Intelligence (AI) has played a promising role in the diagnosis of PD. However, it introduces bias due to lack of sample size, poor validation, clinical evaluation, and lack of big data configuration. The purpose of this study is to compute the risk of bias (RoB) automatically. Method: The PRISMA search strategy was adopted to select the best 39 AI studies out of 85 PD studies closely associated with early diagnosis PD. The studies were used to compute 30 AI attributes (based on 6 AI clusters), using AP(ai)Bias 1.0 (AtheroPointTM, Roseville, CA, USA), and the mean aggregate score was computed. The studies were ranked and two cutoffs (Moderate-Low (ML) and High-Moderate (MH)) were determined to segregate the studies into three bins: low-, moderate-, and high-bias. Result: The ML and HM cutoffs were 3.50 and 2.33, respectively, which constituted 7, 13, and 6 for low-, moderate-, and high-bias studies. The best and worst architectures were “deep learning with sketches as outcomes” and “machine learning with Electroencephalography,” respectively. We recommend (i) the usage of power analysis in big data framework, (ii) that it must undergo scientific validation using unseen AI models, and (iii) that it should be taken towards clinical evaluation for reliability and stability tests. Conclusion: The AI is a vital component for the diagnosis of early PD and the recommendations must be followed to lower the RoB. Full article
Show Figures

Figure 1

44 pages, 2868 KiB  
Review
Comprehensive Survey of Using Machine Learning in the COVID-19 Pandemic
by Nora El-Rashidy, Samir Abdelrazik, Tamer Abuhmed, Eslam Amer, Farman Ali, Jong-Wan Hu and Shaker El-Sappagh
Diagnostics 2021, 11(7), 1155; https://doi.org/10.3390/diagnostics11071155 - 24 Jun 2021
Cited by 55 | Viewed by 7562
Abstract
Since December 2019, the global health population has faced the rapid spreading of coronavirus disease (COVID-19). With the incremental acceleration of the number of infected cases, the World Health Organization (WHO) has reported COVID-19 as an epidemic that puts a heavy burden on [...] Read more.
Since December 2019, the global health population has faced the rapid spreading of coronavirus disease (COVID-19). With the incremental acceleration of the number of infected cases, the World Health Organization (WHO) has reported COVID-19 as an epidemic that puts a heavy burden on healthcare sectors in almost every country. The potential of artificial intelligence (AI) in this context is difficult to ignore. AI companies have been racing to develop innovative tools that contribute to arm the world against this pandemic and minimize the disruption that it may cause. The main objective of this study is to survey the decisive role of AI as a technology used to fight against the COVID-19 pandemic. Five significant applications of AI for COVID-19 were found, including (1) COVID-19 diagnosis using various data types (e.g., images, sound, and text); (2) estimation of the possible future spread of the disease based on the current confirmed cases; (3) association between COVID-19 infection and patient characteristics; (4) vaccine development and drug interaction; and (5) development of supporting applications. This study also introduces a comparison between current COVID-19 datasets. Based on the limitations of the current literature, this review highlights the open research challenges that could inspire the future application of AI in COVID-19. Full article
Show Figures

Figure 1

Back to TopTop